Corrigendum to "The cyclin-dependent kinases pathway as a target for prostate cancer treatment: Rationale and future perspectives" [Crit. Rev. Oncol. Hematol. 157 (January) (2021) 103199].
Crit Rev Oncol Hematol
; 164: 103401, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-34275720
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Crit Rev Oncol Hematol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Country of publication:
Netherlands